Home / Sweden / Vicore Pharma Holding AB
Vicore Pharma Holding AB
Short position disclosed on September 22, 2026.
0.71% of the capital sold short
1 disclosing fund
12 disclosures on record
SE0007577895 ISIN code
Evolution of the disclosed total
0%0.2%0.4%0.6%0.8%
Oct 2025Jan 2026Apr 2026Jul 2026
October 1, 2024 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Citadel Advisors LLC | 0.71% | new | September 22, 2026 |
On the other side: the funds that hold Vicore Pharma Holding AB Titelia
Get the moves on Vicore Pharma Holding AB by mail.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| September 22, 2026 | Citadel Advisors LLC | 0.71% | still open |
| September 15, 2026 | Citadel Advisors LLC | 0.60% | |
| September 11, 2026 | Citadel Advisors LLC | 0.54% | |
| July 31, 2026 | Qube Research & Technologies Limited | 0.70% | |
| July 10, 2026 | Qube Research & Technologies Limited | 0.61% | |
| July 9, 2026 | Qube Research & Technologies Limited | 0.59% | |
| July 8, 2026 | Qube Research & Technologies Limited | 0.60% | |
| July 7, 2026 | Qube Research & Technologies Limited | 0.59% | |
| June 11, 2026 | Qube Research & Technologies Limited | 0.70% | |
| June 4, 2026 | Qube Research & Technologies Limited | 0.61% | |
| June 1, 2026 | Qube Research & Technologies Limited | 0.50% | |
| October 1, 2024 | Jane Street Group LLC | 0.66% |
Download 12 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in Sweden
- Samhällsbyggnadsbolaget i Norden AB 11.99% of the capital sold short
- Elekta AB (publ) 8.98% of the capital sold short
- JM AB 7.61% of the capital sold short
- Truecaller AB 6.87% of the capital sold short
- Bonesupport Holding AB 6.80% of the capital sold short
- Hemnet Group AB (publ) 6.13% of the capital sold short
- RaySearch Laboratories AB (publ) 4.96% of the capital sold short
- Xvivo Perfusion Aktiebolag 4.91% of the capital sold short
- Aktiebolaget Electrolux 4.41% of the capital sold short
- AAK AB (publ) 4.31% of the capital sold short
- Dynavox Group AB 3.88% of the capital sold short
- Hexatronic Group AB 3.69% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Vicore Pharma Holding AB, source Finansinspektionen, data as at September 22, 2026, https://www.quivad.com/action/vicore-pharma-holding-ab